Mean age at index date, yrs (SD) | 63.6 (11.7) | 61.4 (11.0) | 0.195 |
Mean age at menopause, yrs (SD) | 50.7 (2.8) | 40.9 (5.0) | < 0.001 |
RF positivity, n (%) | 331 (66) | 50 (66) | 0.97 |
ESR at RA incidence, mm/h | 33.9 (24.6) | 31.7 (24.5) | 0.36 |
Presence of rheumatoid nodules in the first year after RA incidence, n (%) | 70 (13) | 19 (24) | 0.013 |
Presence of erosions on radiographs in the first year after RA incidence, n (%) | 159 (30) | 21 (27) | 0.48 |
Mean length of followup, yrs (SD) | 11.9 (8.9) | 11.0 (8.1) | — |
Natural menopause, n (%)** | 474 (93) | 46 (58) | < 0.001 |
Artificial menopause, n (%)** | 31 (6) | 33 (42) | < 0.001 |
Type of artificial menopause, n (%) | | | 0.034 |
Still menstruating | 5 (14) | 0 (0.0) | |
Hysterectomy/bilateral oophorectomy | 24 (67) | 27 (82) | |
Bilateral oophorectomy | 2 (6) | 2 (6) | |
Radiation | 4 (11) | 0 (0.0) | |
Chemical | 1 (3) | 1 (3) | |
Other | 0 (0.0) | 3 (9) | |
Mean gravidity (SD) | 3.1 (2.5) | 2.8 (2.6) | 0.392 |
Mean parity (SD) | 2.6 (2.2) | 2.4 (2.1) | 0.568 |
Any pregnancy or live birth, n (%) | 424 (81) | 61 (77) | 0.381 |
Mean age at menarche, yrs (SD) | 13.0 (1.3) | 13.0 (1.5) | 0.470 |
Hormone replacement therapy before RA incidence, n (%) | 144 (28) | 31 (39) | 0.035 |